Market Trends of Asia Pacific Blister Packaging Industry
This section covers the major market trends shaping the APAC Blister Packaging Market according to our research experts:
Pharmaceutical and Healthcare Sector to Account for a Major Share
- The Asia Pacific is the third-largest pharmaceutical market in the world after North America and Europe. The healthcare and pharmaceutical sector poses a different set of demands for the blister packaging solutions, regarding insulation from external surroundings, high levels of protection, cost-effectiveness, and ease of handling.
- When drugs are packaged in blisters, adherence is improved because consumers can keep track of their medications and dosing. Moreover, the unit dosage feature of blisters reduces the risk of incorrect dosing.
- The retail-level preparation of prescription drugs is troubling pharmacists or pharmaceutical technicians. The administration of medicines in the open atmosphere of the supermarket and drug store can negatively affect sensitive drugs when they are transferred from container to container. Blister packaging can ensure the process of distribution directly to the customer.
- Protecting product integrity remains the primary goal of pharmaceutical healthcare packaging. Still, as in all areas of the packaging industry, there is continued work on cost reduction in the packaging process. Moreover, blister packed medicines can prove to be very helpful for the transportation of medicines over long distances.
China to Hold a Significant Share
- The pharmaceutical and healthcare industry holds the dominant share of the blister packaging market in the region, particularly China, as China is the world's one of the largest pharmaceutical market and a strategic priority for most global players. The country is the largest producer of an active pharmaceutical ingredient in the world. The consumer goods sector is also expected to contribute a significant market share over the forecast period.
- According to the China Chamber of Commerce, in 2019, China exported 10.12 million tonnes of APIs, up 8.83% year-on-year. China exports APIs to 189 countries and regions, mainly in Asia, Europe, and North America.
- Blister packaging also provides the possibility to create a compliance pack or calendar pack by labeling the prescription, to which patients can easily adhere. Further, China's massive investments in building up the pipeline of medicines and future drugs can be perceived as an excellent opportunity for the growth of blister packaging in the country.